<DOC>
	<DOCNO>NCT01636934</DOCNO>
	<brief_summary>The goal clinical research study learn minocycline reduce side effect report patient NSCLC receive chemoradiation therapy . In study , minocycline compare placebo . Minocycline antibiotic may help reduce side effect chemoradiation therapy . A placebo drug . It look like study drug design treat disease illness . It design compare study drug learn study drug real effect .</brief_summary>
	<brief_title>Minocycline Study Non Small Cell Lung Cancer ( NSCLC ) Patients Chemoradiation Therapy</brief_title>
	<detailed_description>Study Groups : If agree take part study , randomly assign ( flip coin ) 1 2 group . Group 1 take minocycline . Group 2 take placebo . Neither study staff know receive study drug placebo . However , need safety , study staff able find receiving . Study Drug Administration : You take study drug/placebo mouth , every day chemoradiation therapy . You may take study drug/placebo full glass ( 8 ounce ) water . You may take without food , cause upset stomach , take food . If trouble swallow dose study drug/placebo , open capsule right take . You lie least 30 minute take study drug/placebo reduce risk side effect . You must bring study drug/placebo container ( along remain drug ) every study visit . Study Visits : Before start chemoradiation treatment : - You fill 4 questionnaire pain symptom , tobacco history , health status , quality life . It take 15 minute complete questionnaire . - Blood ( 1 tablespoon ) drawn biomarker test . Biomarkers find blood/tissue may relate reaction study drug . During chemoradiation treatment : - During Week 1 chemoradiation , blood ( 1 tablespoon ) drawn biomarker test . - You complete symptom questionnaire clinic telephone 1 time week . The symptom questionnaire take 5 minute complete time . - Each week ask symptom may may affect daily activity . At Week 4 chemoradiation : -You complete 3 questionnaire pain symptom , health status , quality life . It take 10 minute complete questionnaire . During last week chemoradiation : - You complete 4 questionnaire pain symptom , health status , quality life , satisfaction study drug/placebo . It take 15 minute complete questionnaire . - Blood ( 1 tablespoon ) drawn biomarker test . After last week chemoradiation : - The study staff call 1 time week check complete pain symptom questionnaire time convenient . This phone call last 10 minute . If several side effect chemoradiation therapy , phone call may take long . - At Week 12 , blood ( 1 tablespoon ) drawn biomarker test . End Study Visit : Your last study visit day last clinic visit chemoradiation doctor ( around Weeks 12-13 ) . At visit , complete pain symptom questionnaire , health status questionnaire , smoke questionnaire . It take 10 minute complete questionnaire . Length Study : You study 13 week . You take study drug/placebo every day chemoradiation treatment , continue complete questionnaire 12-13 week . You take study early intolerable side effect study doctor think best interest . This investigational study . Minocycline FDA approve commercially available treatment bacterial infection . Using minocycline treat side effect chemoradiation treatment patient NSCLC investigational . Up 40 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>1 . Patients pathologically proven diagnosis NSCLC consent receive CXRT MD Anderson 2 . Patients &gt; = 18 year old 3 . Patients receive CXRT platinum/taxanebased chemotherapy total radiation dose &gt; = 50 Gy , per treat physician 's assessment 4 . Patients speak English Spanish ( due MDASI language option , accrue Englishspeaking Spanishspeaking patient protocol ) 5 . Patients willing able review , understand , provide write consent start therapy 6 . Patients normal renal function accord MD Anderson testing standard prior renal disease [ screen cut serum creatinine &lt; 1.5 time ULN ] 7 . Patients must follow screen result hepatic function accord MD Anderson test standard : total bilirubin &lt; 1.5 time upper limit normal ; alkaline phosphatase ( ALP ) , alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST available ) must &lt; 2 time upper limit normal 1 . Patients history clinically significant cutaneous drug reaction minocycline , document patient medical record 2 . Patients enrol symptom management symptom clinical trial 3 . Patients currently bile duct obstruction cholelithiasis 4 . Patients hypersensitivity tetracyclines 5 . Patients pregnant ; pregnancy confirm negative urine test 6 . Patients vitamin K antagonist warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Lung Cancer</keyword>
	<keyword>Non Small Cell Lung Cancer</keyword>
	<keyword>NSCLC</keyword>
	<keyword>Symptom Burden</keyword>
	<keyword>Chemoradiation</keyword>
	<keyword>CXRT</keyword>
	<keyword>Minocycline</keyword>
	<keyword>Dynacin</keyword>
	<keyword>Minocin</keyword>
	<keyword>Minocin PAC</keyword>
	<keyword>Myrac</keyword>
	<keyword>Solodyn</keyword>
	<keyword>Placebo</keyword>
	<keyword>Sugar Pill</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
</DOC>